A study on lung cancer and osteosarcoma showed that for drug-resistant lung cancer cells (A549) and osteosarcoma cells (U-2OS), sulforaphane (SFN) inhibited IRF3 activity by activating autophagy through the Nrf2/HO-1 pathway. Here, HMOX1 is linked to lung carcinoma.